{"transactions":[{"id":875073,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2026-03-02T20:38:53.000Z","date":"2026-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":24417,"price":70.93,"value":1731897.81,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock."}],"balance_after":1450716,"source":{"system":"sec-edgar","filing":"0001554855-26-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000155485526000168/form4.xml","form_type":"4"}},{"id":875072,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2026-03-02T20:38:53.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":54949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based stock awards granted on December 7, 2021 (3,935), December 6, 2022 (40,345), December 12, 2023 (5,675) and December 10, 2024 (4,994)."}],"balance_after":1475133,"source":{"system":"sec-edgar","filing":"0001554855-26-000168","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000155485526000168/form4.xml","form_type":"4"}},{"id":971768,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2025-12-12T18:41:14.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":false,"shares":61277,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vested with respect to 20% of the shares on December 10, 2016 and 20% each anniversary thereafter."}],"balance_after":0,"derivative":{"exercise_price":74.72,"expiration_date":"2025-12-10","underlying":"Common Stock","underlying_shares":61277},"source":{"system":"sec-edgar","filing":"0001554855-25-002228","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000155485525002228/form4.xml","form_type":"4"}},{"id":971767,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-12-12T18:41:14.000Z","date":"2025-12-10","kind":"tax_withholding","planned":false,"acquired":false,"shares":60059,"price":77.49,"value":4653971.91,"ownership":{"direct":true},"balance_after":1420184,"source":{"system":"sec-edgar","filing":"0001554855-25-002228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000155485525002228/form4.xml","form_type":"4"}},{"id":971766,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-12-12T18:41:14.000Z","date":"2025-12-10","kind":"exercise","planned":false,"acquired":true,"shares":61277,"price":74.72,"value":4578617.44,"ownership":{"direct":true},"balance_after":1480243,"source":{"system":"sec-edgar","filing":"0001554855-25-002228","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000155485525002228/form4.xml","form_type":"4"}},{"id":1031885,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"ten_percent_owner":true}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":2,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}},{"id":64053,"kind":"person","name":"Brown Michael J","position":3,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":5,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}}],"security":"Common Stock","published_at":"2025-09-26T15:53:30.000Z","date":"2025-09-24","kind":"sale","planned":false,"acquired":false,"shares":550229,"price":63.6098,"value":34999956.6442,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein. The Reporting Persons are no longer subject to Section 16, except for Chandler D. Robinson, who serves as Chief Executive Officer of Monopar Therapeutics Inc."}],"balance_after":272026,"source":{"system":"sec-edgar","filing":"0001437749-25-029925","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774925029925/rdgdoc.xml","form_type":"4"}},{"id":1177879,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"ten_percent_owner":true}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":2,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"officer_title":"Chief Executive Officer"}},{"id":64053,"kind":"person","name":"Brown Michael J","position":3,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":5,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"other":true,"other_text":"Member of 10% Owner Group"}}],"security":"Common Stock","published_at":"2025-04-04T19:27:32.000Z","date":"2025-04-02","kind":"sale","planned":false,"acquired":false,"shares":33334,"price":35,"value":1166690.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.00 to $35.86, inclusive. The reporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":822255,"source":{"system":"sec-edgar","filing":"0001437749-25-011068","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774925011068/rdgdoc.xml","form_type":"4"}},{"id":1204477,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-03-17T19:36:48.000Z","date":"2025-03-13","kind":"sale","planned":false,"acquired":false,"shares":95000,"price":100.69,"value":9565550.0,"ownership":{"direct":true},"balance_after":1418966,"source":{"system":"sec-edgar","filing":"0001213900-25-024528","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025024528/ownership.xml","form_type":"4"}},{"id":1241484,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-02-28T00:00:21.000Z","date":"2025-02-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":17322,"price":102.84,"value":1781394.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock."}],"balance_after":1513966,"source":{"system":"sec-edgar","filing":"0001213900-25-018234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025018234/ownership.xml","form_type":"4"}},{"id":1241483,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-02-28T00:00:21.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":38985,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based stock awards granted on December 7, 2021 (27,546), December 6, 2022 (5,763) and December 12, 2023 (5,676)."}],"balance_after":1531288,"source":{"system":"sec-edgar","filing":"0001213900-25-018234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025018234/ownership.xml","form_type":"4"}},{"id":1268017,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-02-14T21:41:11.000Z","date":"2024-12-23","kind":"gift","planned":false,"acquired":false,"shares":14800,"price":103.75,"value":1535500.0,"ownership":{"direct":true},"balance_after":1492303,"source":{"system":"sec-edgar","filing":"0001213900-25-014344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025014344/ownership.xml","form_type":"5"}},{"id":1268016,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-02-14T21:41:11.000Z","date":"2024-10-25","kind":"gift","planned":false,"acquired":false,"shares":2500,"price":100.5,"value":251250.0,"ownership":{"direct":true},"balance_after":1507103,"source":{"system":"sec-edgar","filing":"0001213900-25-014344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025014344/ownership.xml","form_type":"5"}},{"id":1268015,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2025-02-14T21:41:11.000Z","date":"2024-09-24","kind":"gift","planned":false,"acquired":false,"shares":1000,"price":100.39,"value":100390.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Prior filing incorrectly stated in column 5 of Table I the amount of securities beneficially owned by (i) Mr. Brown individually, (ii) Mr. Brown's spouse, (iii) family trusts for the benefit of Mr. Brown's spouse and children, of which Mr. Brown's spouse is the trustee, and (iv) Mr. Brown's spouse as custodian for his children. The amount of securities beneficially owned is corrected herein."}],"balance_after":1509603,"source":{"system":"sec-edgar","filing":"0001213900-25-014344","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390025014344/ownership.xml","form_type":"5"}},{"id":1334383,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-12T23:09:33.000Z","date":"2024-12-10","kind":"exercise","planned":false,"acquired":true,"shares":117431,"price":104.18,"value":12233961.58,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests 25% per year beginning Dec 10, 2025, contingent on the Company's share price closing above $114.60 for 30 consecutive trading days during the four year measurement period."}],"balance_after":117431,"derivative":{"exercise_price":104.18,"expiration_date":"2034-12-10","underlying":"Common Stock","underlying_shares":117431},"source":{"system":"sec-edgar","filing":"0001213900-24-108506","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390024108506/ownership.xml","form_type":"4"}},{"id":1339419,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-12-09T22:41:24.000Z","date":"2024-12-05","kind":"exercise","planned":false,"acquired":false,"shares":67122,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested with respect to 20% of the shares on December 10, 2015 and 20% each anniversary thereafter."}],"balance_after":0,"derivative":{"exercise_price":56.24,"expiration_date":"2024-12-10","underlying":"Common Stock","underlying_shares":67122},"source":{"system":"sec-edgar","filing":"0001213900-24-107042","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390024107042/ownership.xml","form_type":"4"}},{"id":1339418,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2024-12-09T22:41:24.000Z","date":"2024-12-05","kind":"exercise","planned":false,"acquired":true,"shares":67122,"price":56.24,"value":3774941.28,"ownership":{"direct":true},"balance_after":1583919,"source":{"system":"sec-edgar","filing":"0001213900-24-107042","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390024107042/ownership.xml","form_type":"4"}},{"id":1620269,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2024-02-27T02:03:41.000Z","date":"2024-02-22","kind":"tax_withholding","planned":false,"acquired":false,"shares":5524,"price":107.17,"value":592007.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock."}],"balance_after":1516797,"source":{"system":"sec-edgar","filing":"0001213900-24-017109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390024017109/ownership.xml","form_type":"4"}},{"id":1620268,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2024-02-27T02:03:41.000Z","date":"2024-02-22","kind":"grant","planned":false,"acquired":true,"shares":12395,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based stock awards granted on December 12, 2018 (1,076), December 10, 2019 (1,620), December 7, 2021 (3,935) and December 6, 2022 (5,764)."}],"balance_after":1522321,"source":{"system":"sec-edgar","filing":"0001213900-24-017109","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390024017109/ownership.xml","form_type":"4"}},{"id":1693765,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-01-03T19:40:23.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-24-000487","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774924000487/rdgdoc.xml","form_type":"4"}},{"id":1693764,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-01-03T19:40:23.000Z","date":"2023-12-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":235863,"source":{"system":"sec-edgar","filing":"0001437749-24-000487","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774924000487/rdgdoc.xml","form_type":"4"}},{"id":1711310,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-15T02:59:38.000Z","date":"2023-12-12","kind":"grant","planned":false,"acquired":false,"shares":132470,"price":91.66,"value":12142200.2,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests 25% per year beginning Dec 12, 2024, contingent on the Company's share price closing above $100.83 for 30 consecutive days during the four year measurement period."}],"balance_after":132470,"derivative":{"exercise_price":91.66,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":132470},"source":{"system":"sec-edgar","filing":"0001213900-23-095856","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023095856/ownership.xml","form_type":"4"}},{"id":1722436,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-12-05T22:38:44.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":false,"shares":59324,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested with respect to 20% of the shares on December 10, 2013 and 20% each anniversary thereafter."}],"balance_after":0,"derivative":{"exercise_price":45.93,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":59324},"source":{"system":"sec-edgar","filing":"0001213900-23-093189","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023093189/ownership.xml","form_type":"4"}},{"id":1722435,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-12-05T22:38:44.000Z","date":"2023-12-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":43259,"price":88.87,"value":3844427.33,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.47 to $89.47, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1509926,"source":{"system":"sec-edgar","filing":"0001213900-23-093189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023093189/ownership.xml","form_type":"4"}},{"id":1722434,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-12-05T22:38:44.000Z","date":"2023-12-04","kind":"exercise","planned":false,"acquired":true,"shares":59324,"price":45.93,"value":2724751.32,"ownership":{"direct":true},"balance_after":1553185,"source":{"system":"sec-edgar","filing":"0001213900-23-093189","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023093189/ownership.xml","form_type":"4"}},{"id":1760044,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-10-16T19:49:07.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vested with respect to 20% of the shares on December 10, 2013 and 20% each anniversary thereafter."}],"balance_after":59324,"derivative":{"exercise_price":45.93,"expiration_date":"2023-12-10","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0001013762-23-004099","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000101376223004099/ownership.xml","form_type":"4"}},{"id":1760043,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-10-16T19:49:07.000Z","date":"2023-10-13","kind":"exercise","planned":false,"acquired":true,"shares":8500,"price":45.93,"value":390405.0,"ownership":{"direct":true},"balance_after":1493861,"source":{"system":"sec-edgar","filing":"0001013762-23-004099","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000101376223004099/ownership.xml","form_type":"4"}},{"id":1768316,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-10-03T19:32:04.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2533,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-027584","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923027584/rdgdoc.xml","form_type":"4"}},{"id":1768315,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-10-03T19:32:04.000Z","date":"2023-09-30","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":233330,"source":{"system":"sec-edgar","filing":"0001437749-23-027584","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923027584/rdgdoc.xml","form_type":"4"}},{"id":1772802,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-09-27T20:35:39.000Z","date":"2023-09-26","kind":"gift","planned":false,"acquired":false,"shares":2000,"price":79,"value":158000.0,"ownership":{"direct":true},"balance_after":1485361,"source":{"system":"sec-edgar","filing":"0001213900-23-079928","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023079928/ownership.xml","form_type":"4"}},{"id":1840028,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-07-03T18:49:48.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":false,"shares":2534,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5066,"derivative":{"underlying":"Common Stock","underlying_shares":2534},"source":{"system":"sec-edgar","filing":"0001437749-23-019261","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923019261/rdgdoc.xml","form_type":"4"}},{"id":1840027,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-07-03T18:49:48.000Z","date":"2023-06-30","kind":"exercise","planned":false,"acquired":true,"shares":2534,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":230797,"source":{"system":"sec-edgar","filing":"0001437749-23-019261","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923019261/rdgdoc.xml","form_type":"4"}},{"id":1880130,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-05-24T17:02:00.000Z","date":"2023-05-22","kind":"sale","planned":true,"acquired":false,"shares":6557,"price":121.23,"value":794905.11,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.51, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1487361,"source":{"system":"sec-edgar","filing":"0001213900-23-042630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023042630/ownership.xml","form_type":"4"}},{"id":1880129,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-05-24T17:02:00.000Z","date":"2023-05-22","kind":"sale","planned":true,"acquired":false,"shares":43443,"price":120.61,"value":5239660.23,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.00 to $121.51, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1493918,"source":{"system":"sec-edgar","filing":"0001213900-23-042630","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023042630/ownership.xml","form_type":"4"}},{"id":1929466,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-04T17:19:32.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":false,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 1, 2023, the reporting person was granted 10,133 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2023, June 30, 2023, September 30, 2023, and December 31, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":7600,"derivative":{"underlying":"Common Stock","underlying_shares":2533},"source":{"system":"sec-edgar","filing":"0001437749-23-009335","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923009335/rdgdoc.xml","form_type":"4"}},{"id":1929465,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-04-04T17:19:32.000Z","date":"2023-03-31","kind":"exercise","planned":false,"acquired":true,"shares":2533,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":228263,"source":{"system":"sec-edgar","filing":"0001437749-23-009335","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923009335/rdgdoc.xml","form_type":"4"}},{"id":1993994,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-02-24T22:27:42.000Z","date":"2023-02-22","kind":"grant","acquired":true,"shares":7937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based stock awards granted on December 12, 2017 (1,304), December 12, 2018 (1,077), December 10, 2019 (1,621) and December 7, 2021 (3,935)."}],"balance_after":1537361,"source":{"system":"sec-edgar","filing":"0001213900-23-014432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023014432/ownership.xml","form_type":"4"}},{"id":1993993,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-02-24T22:27:42.000Z","date":"2023-02-22","kind":"gift","acquired":false,"shares":988,"price":107.56,"value":106269.28,"ownership":{"direct":true},"balance_after":1529424,"source":{"system":"sec-edgar","filing":"0001213900-23-014432","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023014432/ownership.xml","form_type":"4"}},{"id":2033621,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-02-03T18:50:29.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":10133,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":10133,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10133},"source":{"system":"sec-edgar","filing":"0001437749-23-002519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923002519/rdgdoc.xml","form_type":"4"}},{"id":2033620,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Stock Options","published_at":"2023-02-03T18:50:29.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":13930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023."}],"balance_after":13930,"derivative":{"exercise_price":3.16,"expiration_date":"2033-02-01","underlying":"Common Stock","underlying_shares":13930},"source":{"system":"sec-edgar","filing":"0001437749-23-002519","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923002519/rdgdoc.xml","form_type":"4"}},{"id":2036844,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2023-02-02T21:38:38.000Z","date":"2023-02-01","kind":"gift","acquired":false,"shares":2000,"price":115.45,"value":230900.0,"ownership":{"direct":true},"balance_after":1530412,"source":{"system":"sec-edgar","filing":"0001213900-23-007397","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390023007397/ownership.xml","form_type":"4"}},{"id":2073043,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-01-03T16:10:16.000Z","date":"2022-12-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 2, 2022, the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001437749-23-000172","document":"rdgdoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923000172/rdgdoc.xml","form_type":"4"}},{"id":2073042,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-01-03T16:10:16.000Z","date":"2022-12-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":225730,"source":{"system":"sec-edgar","filing":"0001437749-23-000172","document":"rdgdoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000143774923000172/rdgdoc.xml","form_type":"4"}},{"id":2075147,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-12-29T18:30:00.000Z","date":"2022-12-27","kind":"gift","acquired":false,"shares":220,"price":93.37,"value":20541.4,"ownership":{"direct":true},"balance_after":1532192,"source":{"system":"sec-edgar","filing":"0001213900-22-083459","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022083459/ownership.xml","form_type":"4"}},{"id":2086851,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-12-14T22:03:05.000Z","date":"2022-12-13","kind":"gift","acquired":false,"shares":2000,"price":92.37,"value":184740.0,"ownership":{"direct":true},"balance_after":1532412,"source":{"system":"sec-edgar","filing":"0001213900-22-079829","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022079829/ownership.xml","form_type":"4"}},{"id":2092495,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-09T00:42:59.000Z","date":"2022-12-06","kind":"grant","acquired":false,"shares":141290,"price":90.26,"value":12752835.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award vests 25% per year beginning Dec 6, 2023, contingent on the Company's share price closing above $99.29 for 30 consecutive days during the four year measurement period."}],"balance_after":141290,"derivative":{"exercise_price":90.26,"expiration_date":"2032-12-06","underlying":"Common Stock","underlying_shares":141290},"source":{"system":"sec-edgar","filing":"0001213900-22-078552","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022078552/ownership.xml","form_type":"4"}},{"id":2098825,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-12-02T18:11:10.000Z","date":"2022-11-30","kind":"exercise","acquired":false,"shares":76844,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option vested with respect to 20% of the shares on December 11, 2013 and 20% each anniversary thereafter."}],"balance_after":0,"derivative":{"exercise_price":23.63,"expiration_date":"2022-12-11","underlying":"Common Stock","underlying_shares":76844},"source":{"system":"sec-edgar","filing":"0001213900-22-077150","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022077150/ownership.xml","form_type":"4"}},{"id":2098824,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-12-02T18:11:10.000Z","date":"2022-11-30","kind":"exercise","acquired":true,"shares":76844,"price":23.63,"value":1815823.72,"ownership":{"direct":true},"balance_after":1534207,"source":{"system":"sec-edgar","filing":"0001213900-22-077150","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022077150/ownership.xml","form_type":"4"}},{"id":2107369,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-11-22T22:26:01.000Z","date":"2022-11-18","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This option vests with respect to 20% of the shares on December 11, 2013 and 20% each anniversary thereafter."}],"balance_after":76844,"derivative":{"exercise_price":23.63,"expiration_date":"2022-12-11","underlying":"Employee Stock Option (right to buy)","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001213900-22-074641","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022074641/ownership.xml","form_type":"4"}},{"id":2107368,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-11-22T22:26:01.000Z","date":"2022-11-21","kind":"gift","acquired":false,"shares":5400,"price":89.4,"value":482760.0,"ownership":{"direct":true},"balance_after":1457363,"source":{"system":"sec-edgar","filing":"0001213900-22-074641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022074641/ownership.xml","form_type":"4"}},{"id":2107367,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-11-22T22:26:01.000Z","date":"2022-11-21","kind":"gift","acquired":false,"shares":5000,"price":89.4,"value":447000.0,"ownership":{"direct":true},"balance_after":1462763,"source":{"system":"sec-edgar","filing":"0001213900-22-074641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022074641/ownership.xml","form_type":"4"}},{"id":2107366,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-11-22T22:26:01.000Z","date":"2022-11-18","kind":"sale","acquired":false,"shares":15689,"price":89.87,"value":1409970.43,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $89.50 to $90.16, inclusive. The Reporting Person undertakes to provide to Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1467763,"source":{"system":"sec-edgar","filing":"0001213900-22-074641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022074641/ownership.xml","form_type":"4"}},{"id":2107365,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-11-22T22:26:01.000Z","date":"2022-11-18","kind":"exercise","acquired":true,"shares":25000,"price":23.63,"value":590750.0,"ownership":{"direct":true},"balance_after":1483452,"source":{"system":"sec-edgar","filing":"0001213900-22-074641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022074641/ownership.xml","form_type":"4"}},{"id":2147769,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-10-03T19:41:14.000Z","date":"2022-09-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2859,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-013277","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422013277/section16.xml","form_type":"4"}},{"id":2147768,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-10-03T19:41:14.000Z","date":"2022-09-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":222871,"source":{"system":"sec-edgar","filing":"0001654954-22-013277","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422013277/section16.xml","form_type":"4"}},{"id":2217644,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-07-01T16:15:58.000Z","date":"2022-06-30","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":5718,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-009146","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422009146/section16.xml","form_type":"4"}},{"id":2217643,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-07-01T16:15:58.000Z","date":"2022-06-30","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":220012,"source":{"system":"sec-edgar","filing":"0001654954-22-009146","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422009146/section16.xml","form_type":"4"}},{"id":2270793,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-05-16T21:16:57.000Z","date":"2022-05-12","kind":"sale","acquired":false,"shares":10000,"price":111.11,"value":1111100.0,"ownership":{"direct":false,"nature":"By Spouse"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.04 to $111.47, inclusive. The Reporting Person undertakes to provide Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":24000,"source":{"system":"sec-edgar","filing":"0001213900-22-027240","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022027240/ownership.xml","form_type":"4"}},{"id":2311600,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-04-01T17:02:39.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":2859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 2, 2022 the reporting person was granted 11,436 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2022, June 30, 2022, September 30, 2022, and December 31, 2022. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":8577,"derivative":{"underlying":"Common Stock","underlying_shares":2859},"source":{"system":"sec-edgar","filing":"0001654954-22-004478","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422004478/section16.xml","form_type":"4"}},{"id":2311599,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-04-01T17:02:39.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":2859,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":217153,"source":{"system":"sec-edgar","filing":"0001654954-22-004478","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422004478/section16.xml","form_type":"4"}},{"id":2375689,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-02-24T21:14:17.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":5629,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based restricted stock awards granted on December 13, 2016 (1,627), December 12, 2017 (1,305), December 12, 2018 (1,077), December 10, 2019 (1,620)."}],"balance_after":1458752,"source":{"system":"sec-edgar","filing":"0001213900-22-009211","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022009211/ownership.xml","form_type":"4"}},{"id":2398914,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2022-02-14T21:00:36.000Z","date":"2021-12-30","kind":"gift","acquired":false,"shares":250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1453123,"source":{"system":"sec-edgar","filing":"0001213900-22-007470","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390022007470/ownership.xml","form_type":"5"}},{"id":2411909,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-02-04T19:34:28.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":11436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":11436,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":11436},"source":{"system":"sec-edgar","filing":"0001654954-22-001170","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422001170/section16.xml","form_type":"4"}},{"id":2411908,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2022-02-04T19:34:28.000Z","date":"2022-02-02","kind":"grant","acquired":true,"shares":15128,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022."}],"balance_after":15128,"derivative":{"exercise_price":2.8,"expiration_date":"2032-02-01","underlying":"Common Stock","underlying_shares":15128},"source":{"system":"sec-edgar","filing":"0001654954-22-001170","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422001170/section16.xml","form_type":"4"}},{"id":2450486,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2022-01-04T13:36:38.000Z","date":"2021-12-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-22-000119","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422000119/section16.xml","form_type":"4"}},{"id":2450485,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2022-01-04T13:36:38.000Z","date":"2021-12-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":214294,"source":{"system":"sec-edgar","filing":"0001654954-22-000119","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495422000119/section16.xml","form_type":"4"}},{"id":2479353,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-09T23:07:39.000Z","date":"2021-12-07","kind":"grant","acquired":false,"shares":113346,"price":116.08,"value":13157203.68,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The award vests 25% per year beginning December 7, 2022, contingent on the Company's share price closing above $127.69 for 30 consecutive days during the four year measurement period."}],"balance_after":113346,"derivative":{"exercise_price":116.08,"expiration_date":"2031-12-07","underlying":"Common Stock","underlying_shares":113346},"source":{"system":"sec-edgar","filing":"0001213900-21-064469","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021064469/ownership.xml","form_type":"4"}},{"id":2479352,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-12-09T23:07:39.000Z","date":"2021-12-08","kind":"grant","acquired":true,"shares":9784,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from time-based restricted stock awards granted on December 8, 2020."}],"balance_after":1453373,"source":{"system":"sec-edgar","filing":"0001213900-21-064469","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021064469/ownership.xml","form_type":"4"}},{"id":2482831,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-12-07T13:18:34.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":100379,"price":16.39,"value":1645211.81,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":16.39,"exercise_date":"2016-12-14","expiration_date":"2021-12-14","underlying":"Common Stock","underlying_shares":100379},"source":{"system":"sec-edgar","filing":"0001213900-21-063797","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021063797/ownership.xml","form_type":"4"}},{"id":2482830,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-12-07T13:18:34.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":100379,"price":16.39,"value":1645211.81,"ownership":{"direct":true},"balance_after":1443589,"source":{"system":"sec-edgar","filing":"0001213900-21-063797","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021063797/ownership.xml","form_type":"4"}},{"id":2523349,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-11-05T20:01:28.000Z","date":"2021-11-03","kind":"exercise","acquired":false,"shares":21600,"price":16.39,"value":354024.0,"ownership":{"direct":true},"balance_after":100379,"derivative":{"exercise_price":16.39,"exercise_date":"2016-12-14","expiration_date":"2021-12-14","underlying":"Common Stock","underlying_shares":21600},"source":{"system":"sec-edgar","filing":"0001213900-21-057012","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021057012/ownership.xml","form_type":"4"}},{"id":2523348,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-11-05T20:01:28.000Z","date":"2021-11-03","kind":"exercise","acquired":true,"shares":21600,"price":16.39,"value":354024.0,"ownership":{"direct":true},"balance_after":1343210,"source":{"system":"sec-edgar","filing":"0001213900-21-057012","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021057012/ownership.xml","form_type":"4"}},{"id":2554830,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-10-01T19:22:59.000Z","date":"2021-09-30","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":751,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-010714","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421010714/section16.xml","form_type":"4"}},{"id":2554829,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-10-01T19:22:59.000Z","date":"2021-09-30","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":213543,"source":{"system":"sec-edgar","filing":"0001654954-21-010714","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421010714/section16.xml","form_type":"4"}},{"id":2558004,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc"}}],"security":"Employee Stock Option (right to buy)","published_at":"2021-09-28T20:15:59.000Z","date":"2021-09-24","kind":"exercise","acquired":false,"shares":24300,"price":16.39,"value":398277.0,"ownership":{"direct":true},"balance_after":121979,"derivative":{"exercise_price":16.39,"exercise_date":"2016-12-14","expiration_date":"2021-12-14","underlying":"Common Stock","underlying_shares":24300},"source":{"system":"sec-edgar","filing":"0001213900-21-050311","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021050311/ownership.xml","form_type":"4"}},{"id":2558003,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc"}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-09-28T20:15:59.000Z","date":"2021-09-24","kind":"exercise","acquired":true,"shares":24300,"price":16.39,"value":398277.0,"ownership":{"direct":true},"balance_after":1321610,"source":{"system":"sec-edgar","filing":"0001213900-21-050311","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021050311/ownership.xml","form_type":"4"}},{"id":2645557,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-07-02T17:18:09.000Z","date":"2021-06-30","kind":"exercise","acquired":false,"shares":752,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":1502,"derivative":{"underlying":"Common Stock","underlying_shares":752},"source":{"system":"sec-edgar","filing":"0001654954-21-007603","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421007603/section16.xml","form_type":"4"}},{"id":2645556,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-07-02T17:18:09.000Z","date":"2021-06-30","kind":"exercise","acquired":true,"shares":752,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":212792,"source":{"system":"sec-edgar","filing":"0001654954-21-007603","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421007603/section16.xml","form_type":"4"}},{"id":2764804,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-04-01T19:42:36.000Z","date":"2021-03-31","kind":"exercise","acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 26, 2021 the reporting person was granted 3,005 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2021, June 30, 2021, September 30, 2021, and December 31, 2021. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":2254,"derivative":{"underlying":"Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001654954-21-003791","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421003791/section16.xml","form_type":"4"}},{"id":2764803,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-04-01T19:42:36.000Z","date":"2021-03-31","kind":"exercise","acquired":true,"shares":751,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":212040,"source":{"system":"sec-edgar","filing":"0001654954-21-003791","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421003791/section16.xml","form_type":"4"}},{"id":2833405,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-02-25T22:17:22.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":2249,"price":156.27,"value":351451.23,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents shares surrendered to Euronet Worldwide, Inc. by the Reporting Person to satisfy tax withholding liability obligations associated with the vesting of performance-based restricted stock."}],"balance_after":1297310,"source":{"system":"sec-edgar","filing":"0001213900-21-011716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021011716/ownership.xml","form_type":"4"}},{"id":2833404,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2021-02-25T22:17:22.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":7236,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Vesting of shares from performance-based restricted stock awards granted on December 10, 2015 (1,606), December 13, 2016 (1,628), December 12, 2017 (1,304), December 12, 2018 (1,077), and December 10, 2019 (1,621)."}],"balance_after":1299559,"source":{"system":"sec-edgar","filing":"0001213900-21-011716","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390021011716/ownership.xml","form_type":"4"}},{"id":2859929,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":11929,"price":16.9,"value":201600.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.77 to $17.01, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":166667,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859928,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":16384,"price":16.44,"value":269352.96,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.77 to $16.76, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":178596,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859927,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":29996,"price":15.12,"value":453539.52,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.76 to $15.75, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":194980,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859926,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":24224,"price":14.09,"value":341316.16,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.66 to $14.54, inclusive."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":224976,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2859925,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":74939,"kind":"organization","name":"Tactic Pharma LLC","position":1,"cik":"0001727357","reported_name":"Tactic Pharma LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":54676,"kind":"person","name":"Mazar Andrew Paul","position":2,"cik":"0001727393","reported_name":"Mazar Andrew Paul","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Scientific Officer"}},{"id":32623,"kind":"person","name":"Robinson Chandler","position":3,"cik":"0001727334","reported_name":"Robinson Chandler","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"officer_title":"Chief Executive Officer"}},{"id":74940,"kind":"person","name":"O'Halloran Thomas V.","position":4,"cik":"0001727481","reported_name":"O'Halloran Thomas V.","relationship":{"director":false,"officer":false,"ten_percent_owner":true}},{"id":64053,"kind":"person","name":"Brown Michael J","position":5,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common stock","published_at":"2021-02-16T19:35:11.000Z","date":"2021-02-11","kind":"sale","acquired":false,"shares":42467,"price":13.3,"value":564811.1,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"Trade made pursuant to a 10b5-1 plan executed on November 24, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.66 to $13.65, inclusive. The\nreporting person undertakes to provide to Monopar Therapeutics Inc., any security holder of Monopar Therapeutics Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3) through (7) to this Form 4."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company (\"Tactic\"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the \"Reporting Persons\"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein."}],"balance_after":249200,"source":{"system":"sec-edgar","filing":"0001654954-21-001750","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421001750/section16.xml","form_type":"4"}},{"id":2892475,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-28T18:56:19.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"RSUs vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":3005,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001654954-21-000919","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000919/section16.xml","form_type":"4"}},{"id":2892474,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Stock Options","published_at":"2021-01-28T18:56:19.000Z","date":"2021-01-26","kind":"grant","acquired":true,"shares":4443,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options vest 25% quarterly on March 31, 2021, June 30, 2021, September 30, 2021 and December 31, 2021."}],"balance_after":4443,"derivative":{"exercise_price":6.81,"expiration_date":"2031-01-25","underlying":"Common Stock","underlying_shares":4443},"source":{"system":"sec-edgar","filing":"0001654954-21-000919","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000919/section16.xml","form_type":"4"}},{"id":2916459,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-06T12:44:35.000Z","date":"2020-12-31","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000184","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000184/section16.xml","form_type":"4"}},{"id":2916458,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Restricted Stock Units","published_at":"2021-01-06T12:44:35.000Z","date":"2020-09-30","kind":"exercise","acquired":false,"shares":322,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On January 31, 2020 the reporting person was granted 1,289 restricted stock units, vesting in four equal quarterly installments with vesting dates on March 31, 2020, June 30, 2020, September 30, 2020, and December 31, 2020. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.  Disposed of restricted stock units were surrendered in exchange for issuance of common stock upon vesting and settlement."}],"balance_after":322,"derivative":{"underlying":"Common Stock","underlying_shares":322},"source":{"system":"sec-edgar","filing":"0001654954-21-000184","document":"section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000184/section16.xml","form_type":"4"}},{"id":2916457,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-06T12:44:35.000Z","date":"2020-12-31","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":211289,"source":{"system":"sec-edgar","filing":"0001654954-21-000184","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000184/section16.xml","form_type":"4"}},{"id":2916456,"issuer":{"id":5152,"kind":"organization","name":"Monopar Therapeutics","symbol":"MNPR"},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":false,"ten_percent_owner":false}}],"security":"Common Stock","published_at":"2021-01-06T12:44:35.000Z","date":"2020-09-30","kind":"exercise","acquired":true,"shares":322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares acquired on vesting and settlement of restricted stock units."}],"balance_after":210967,"source":{"system":"sec-edgar","filing":"0001654954-21-000184","document":"section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1035909/000165495421000184/section16.xml","form_type":"4"}},{"id":2950418,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-10T21:00:13.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Up to one third of the shares for this option grant vests upon filing of the 2021 annual report on Form 10-K, and up to two thirds of the shares for this option grant vest upon the earlier of December 8, 2022 or the filing of the 2022 annual report on Form 10-K, and up to 100% of the shares for this option grant vest upon the earlier of December 8, 2023 or the filing of the 2023 annual report on Form 10-K, contingent on the Company achieving certain performance criteria."}],"balance_after":75000,"derivative":{"exercise_price":133.22,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-20-042011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020042011/ownership.xml","form_type":"4"}},{"id":2950417,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Employee Stock Option (right to buy)","published_at":"2020-12-10T21:00:13.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One third of the shares for this option grant vests on December 8, 2021 and one third on each anniversary thereafter."}],"balance_after":75000,"derivative":{"exercise_price":133.22,"expiration_date":"2030-12-08","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001213900-20-042011","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020042011/ownership.xml","form_type":"4"}},{"id":2973528,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":4723,"price":132.3,"value":624852.9,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $132.08 to $132.73, inclusive. The Reporting Person undertakes to provide Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1292323,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}},{"id":2973527,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-18","kind":"sale","acquired":false,"shares":16906,"price":131.85,"value":2229056.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $131.07 to $132.07, inclusive. The Reporting Person undertakes to provide Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1297046,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}},{"id":2973526,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-18","kind":"exercise","acquired":true,"shares":41909,"price":17.05,"value":714548.45,"ownership":{"direct":true},"balance_after":1313952,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}},{"id":2973525,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":5653,"price":127.21,"value":719118.13,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $127.03 to $127.43, inclusive. The Reporting Person undertakes to provide Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1272043,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}},{"id":2973524,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-17","kind":"sale","acquired":false,"shares":15080,"price":126.6,"value":1909128.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.02 to $127.02, inclusive. The Reporting Person undertakes to provide Euronet Worldwide, Inc., any security holder of Euronet Worldwide, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range referred herein."}],"balance_after":1277696,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}},{"id":2973523,"issuer":{"id":4336,"kind":"organization","name":"EURONET WORLDWIDE, INC."},"owners":[{"id":64053,"kind":"person","name":"Brown Michael J","position":1,"cik":"0001035909","reported_name":"Brown Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO & President of EWI Inc."}}],"security":"Common Stock, par value $0.02 per share","published_at":"2020-11-19T17:02:53.000Z","date":"2020-11-17","kind":"exercise","acquired":true,"shares":40000,"price":17.05,"value":682000.0,"ownership":{"direct":true},"balance_after":1292776,"source":{"system":"sec-edgar","filing":"0001213900-20-038158","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1029199/000121390020038158/ownership.xml","form_type":"4"}}],"next_cursor":"2020-11-19T17:02:53.000000Z,2973523"}